Literature DB >> 30055151

Deep Scleral Exposure: A Degenerative Outcome of End-Stage Stargardt Disease.

Winston Lee1, Jana Zernant1, Takayuki Nagasaki1, Stephen H Tsang1, Rando Allikmets2.   

Abstract

PURPOSE: To describe a distinct phenotypic outcome of outer retinal degeneration in a cohort of genetically confirmed patients with recessive Stargardt disease (STGD1).
DESIGN: Retrospective case series.
METHODS: Twelve patients, who were clinically diagnosed with STGD1 and exhibited a unique degenerative phenotype, were included in the study. Two disease-causing mutations were found in all patients by direct sequencing of the ABCA4 gene. Clinical characterization of patients were defined on fundus photographs, autofluorescence images (488-nm and 532-nm excitation), spectral-domain optical coherence tomography (SD-OCT), and full-field electroretinogram (ffERG) testing.
RESULTS: Mean age at initial presentation was 67.8 years and reported age of symptomatic onset was 14.1 years (mean disease duration = 53.8 years). Best-corrected visual acuity ranged from 20/400 to hand motion. All patients exhibited advanced degeneration across the posterior pole resulting in a reflectively pale, blonde fundus owing to unobstructed exposure of the underlying sclera. SD-OCT revealed complete loss of the outer retinal bands (external limiting membrane, ellipsoid zone, interdigitation zone, and retinal pigment epithelium) and choroidal layers. Scotopic and photopic waveforms on ffERG were nonrecordable or severely attenuated in 8 patients who were tested.
CONCLUSIONS: Widespread scleral exposure is a clinical outcome in a subset of STGD1 following a long duration of disease progression (∼50 years). The blonde fundus in such cases may exhibit phenotypic overlap and shared therapeutic implications with other aggressive chorioretinal dystrophies such as end-stage choroideremia, gyrate atrophy, or RPE65-Leber congenital amaurosis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30055151      PMCID: PMC6547128          DOI: 10.1016/j.ajo.2018.07.018

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  68 in total

1.  Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration.

Authors:  Robert E MacLaren; Alan C Bird; P Julie Sathia; G William Aylward
Journal:  Ophthalmology       Date:  2005-12       Impact factor: 12.079

2.  Clinical and functional findings in choroideremia due to complete deletion of the CHM gene.

Authors:  Marco Mura; Christina Sereda; Monica M Jablonski; Ian M MacDonald; Alessandro Iannaccone
Journal:  Arch Ophthalmol       Date:  2007-08

3.  G1961E mutant allele in the Stargardt disease gene ABCA4 causes bull's eye maculopathy.

Authors:  Wener Cella; Vivienne C Greenstein; Jana Zernant-Rajang; Theodore R Smith; Gaetano Barile; Rando Allikmets; Stephen H Tsang
Journal:  Exp Eye Res       Date:  2009-02-13       Impact factor: 3.467

4.  Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR.

Authors:  A Martínez-Mir; E Paloma; R Allikmets; C Ayuso; T del Rio; M Dean; L Vilageliu; R Gonzàlez-Duarte; S Balcells
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

5.  Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR.

Authors:  F P Cremers; D J van de Pol; M van Driel; A I den Hollander; F J van Haren; N V Knoers; N Tijmes; A A Bergen; K Rohrschneider; A Blankenagel; A J Pinckers; A F Deutman; C B Hoyng
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

6.  Evaluation of retinal photoreceptors and pigment epithelium in a female carrier of choroideremia.

Authors:  N Syed; J E Smith; S K John; M C Seabra; G D Aguirre; A H Milam
Journal:  Ophthalmology       Date:  2001-04       Impact factor: 12.079

7.  Choroideremia: analysis of the retina from a female symptomatic carrier.

Authors:  Vera L Bonilha; Karmen M Trzupek; Yong Li; Peter J Francis; Joe G Hollyfield; Mary E Rayborn; Nizar Smaoui; Richard G Weleber
Journal:  Ophthalmic Genet       Date:  2008-09       Impact factor: 1.803

8.  Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence.

Authors:  Artur V Cideciyan; Tomas S Aleman; Malgorzata Swider; Sharon B Schwartz; Janet D Steinberg; Alexander J Brucker; Albert M Maguire; Jean Bennett; Edwin M Stone; Samuel G Jacobson
Journal:  Hum Mol Genet       Date:  2004-01-06       Impact factor: 6.150

9.  RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease.

Authors:  Hui Y Xiong; Babak Alipanahi; Leo J Lee; Hannes Bretschneider; Daniele Merico; Ryan K C Yuen; Yimin Hua; Serge Gueroussov; Hamed S Najafabadi; Timothy R Hughes; Quaid Morris; Yoseph Barash; Adrian R Krainer; Nebojsa Jojic; Stephen W Scherer; Benjamin J Blencowe; Brendan J Frey
Journal:  Science       Date:  2014-12-18       Impact factor: 47.728

10.  A drosophila genetic resource of mutants to study mechanisms underlying human genetic diseases.

Authors:  Shinya Yamamoto; Manish Jaiswal; Wu-Lin Charng; Tomasz Gambin; Ender Karaca; Ghayda Mirzaa; Wojciech Wiszniewski; Hector Sandoval; Nele A Haelterman; Bo Xiong; Ke Zhang; Vafa Bayat; Gabriela David; Tongchao Li; Kuchuan Chen; Upasana Gala; Tamar Harel; Davut Pehlivan; Samantha Penney; Lisenka E L M Vissers; Joep de Ligt; Shalini N Jhangiani; Yajing Xie; Stephen H Tsang; Yesim Parman; Merve Sivaci; Esra Battaloglu; Donna Muzny; Ying-Wooi Wan; Zhandong Liu; Alexander T Lin-Moore; Robin D Clark; Cynthia J Curry; Nichole Link; Karen L Schulze; Eric Boerwinkle; William B Dobyns; Rando Allikmets; Richard A Gibbs; Rui Chen; James R Lupski; Michael F Wangler; Hugo J Bellen
Journal:  Cell       Date:  2014-09-25       Impact factor: 66.850

View more
  5 in total

Review 1.  Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations.

Authors:  Frans P M Cremers; Winston Lee; Rob W J Collin; Rando Allikmets
Journal:  Prog Retin Eye Res       Date:  2020-04-09       Impact factor: 21.198

Review 2.  An Overview of the Genetics of ABCA4 Retinopathies, an Evolving Story.

Authors:  Saoud Al-Khuzaei; Suzanne Broadgate; Charlotte R Foster; Mital Shah; Jing Yu; Susan M Downes; Stephanie Halford
Journal:  Genes (Basel)       Date:  2021-08-13       Impact factor: 4.096

Review 3.  The role of multimodal imaging and vision function testing in ABCA4-related retinopathies and their relevance to future therapeutic interventions.

Authors:  Saoud Al-Khuzaei; Mital Shah; Charlotte R Foster; Jing Yu; Suzanne Broadgate; Stephanie Halford; Susan M Downes
Journal:  Ther Adv Ophthalmol       Date:  2021-12-19

4.  A genotype-phenotype correlation matrix for ABCA4 disease based on long-term prognostic outcomes.

Authors:  Winston Lee; Jana Zernant; Pei-Yin Su; Takayuki Nagasaki; Stephen H Tsang; Rando Allikmets
Journal:  JCI Insight       Date:  2022-01-25

5.  Rare and common variants in ROM1 and PRPH2 genes trans-modify Stargardt/ABCA4 disease.

Authors:  Jana Zernant; Winston Lee; Jun Wang; Kerry Goetz; Ehsan Ullah; Takayuki Nagasaki; Pei-Yin Su; Gerald A Fishman; Stephen H Tsang; Santa J Tumminia; Brian P Brooks; Robert B Hufnagel; Rui Chen; Rando Allikmets
Journal:  PLoS Genet       Date:  2022-03-30       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.